Clinical Trial Update: Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating apatinib in combination with chemotherapy for esophageal squamous cell carcinoma after failure of standard treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: The First Affiliated Hospital of Anhui Medical University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN